2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolismAlex C. Spyropoulos|European Heart Journal|2014Cited by 3.1k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-UpBehnood Bikdeli, Gregory Y.H. Lip, Jawed Fareed et al.|Journal of the American College of Cardiology|2020Cited by 2.9k
Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTHScott Kaatz, Sam Schulman, Ahmad Danesh et al.|Journal of Thrombosis and Haemostasis|2015Cited by 1.4k
Perioperative Bridging Anticoagulation in Patients with Atrial FibrillationJames D. Douketis, Thomas L. Ortel, Alex C. Spyropoulos et al.|New England Journal of Medicine|2015Cited by 1.2k
Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical PatientsAlexander T Cohen, Victor F. Tapson, Theodore E. Spiro et al.|New England Journal of Medicine|2013Cited by 603